View More Recent Stories
-
GoodRx Holdings (GDRX) Appoints Healthcare Industry Veteran, Wendy Barnes, as New Chief Executive Officer
-
Mizuho Starts GoodRx Holdings Inc. (GDRX) at Neutral
-
GoodRx Holdings, Inc. (GDRX) Misses Q3 EPS by 1c ; Offers Guidance
-
GoodRx (GDRX) offers exclusive low cash price for weight management drug QSYMIA
-
GoodRx Holdings, Inc. (GDRX) Appoints Ronald E. Bruehlman to its Board
-
TD Cowen Reiterates Buy Rating on GoodRx Holdings Inc. (GDRX)
-
Leerink Partners Reiterates Outperform Rating on GoodRx Holdings Inc. (GDRX)
-
TD Cowen Reiterates Buy Rating on GoodRx Holdings Inc. (GDRX)
-
GoodRx Holdings, Inc. (GDRX) Reports In-Line Q2 EPS ; Offers Guidance
-
TD Cowen Reiterates Buy Rating on GoodRx Holdings Inc. (GDRX)
-
GoodRx (GDRX) and Boehringer Ingelheim enter exclusive patient affordability initiative for Adalimumab-adbm injection
-
RBC Capital Reiterates Outperform Rating on GoodRx Holdings Inc. (GDRX)
-
GoodRx Holdings, Inc. (GDRX) Appoints Ian T. Clark to its Board
-
GoodRx (GDRX) named Best Smidcap Idea at TD Cowen
-
GoodRx Holdings Inc. (GDRX) PT Raised to $9.50 at Morgan Stanley

